Hair loss. Nonscarring hair loss, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Male aged 18-55 years General health Hair Loss Status II, III, IV Based on Norwood Scale Voluntary participation and signing written informed consent
Exclusion criteria
Exclusion criteria: Chronic active scalp disease other than hair loss Using any prescribed drug or OTC for hair loss within the past 3 months Documented sensitivity to formulation components Any severe weight loss or strict diet therapy during the study Oral or topical treatment of minoxidil within 6 months before entering the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Count changes in terminal hair. Timepoint: Before intervention, 8,16,24 and 32 weeks after the start of use. Method of measurement: Trichoscopy By Fotofinder device. | — |
Secondary
| Measure | Time frame |
|---|---|
| Hair count changes. Timepoint: Before intervention, 8, 16 and 32 weeks after the start of use. Method of measurement: Trichoscopy By Fotofinder device.;Hair lost Changes, based on Global photographic review. Timepoint: Before intervention, 8, 16 and 32 weeks after the start of use. Method of measurement: One independent dermatologist will perform clinical assessments in a blinded fashion by scoring every photograph according to the "Global photographic review" scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Tehran University of Medical Sciences